Paid Clinical Trials Fresno

Discover 200 paid clinical trials in Fresno, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 200

KC002Safety and Efficacy Study of an Interactive Wound Dressing (KC002) for the Treatment of Diabetic Foot Ulcers

Recruiting

PHASE2

Sponsor:

KeraCure

Location:

Fresno CA, San Francisco CA, Los Angeles CA, St. George UTshow 17 more

Code:

NCT00330265

Conditions

Foot Ulcer

Diabetes

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

KC-002

Conventional Wound Therapy

Thoracotomy vs. ThoracoscopicThoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

Recruiting

PHASE3

Sponsor:

Children's Oncology Group

Location:

Madera CA, Arroyo Grande CA, Palo Alto CA, Oakland CAshow 144 more

Code:

NCT05235165

Conditions

Metastatic Malignant Neoplasm in the Lung

Metastatic Osteosarcoma

Osteosarcoma

Eligibility Criteria

Sex: All

Age: 0 - 50

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Computed Tomography

Questionnaire Administration

Thoracoscopy

Thoracotomy

Observational StudyRegistry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

Recruiting

Sponsor:

Novartis Pharmaceuticals

Location:

Madera CA, Sacramento CA, Los Angeles CA, Loma Linda CAshow 44 more

Code:

NCT04174157

Conditions

Spinal Muscular Atrophy (SMA)

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Prospective observational registry

Zolgensma

Steroids & TKIsTesting the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults

Recruiting

PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Clovis CA, Burbank CA, Duarte CA, Orange CAshow 142 more

Code:

NCT04530565

Conditions

B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Blinatumomab

Bone Marrow Aspiration and Biopsy

Cyclophosphamide

Cytarabine

Zongertinib vs. Standard TreatmentBeamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment

Recruiting

PHASE3

Sponsor:

Boehringer Ingelheim

Location:

Fresno CA, Reno NV, Glendale CA, Beverly Hills CAshow 17 more

Code:

NCT06151574

Conditions

Lung Cancer, Non-squamous, Non-small Cell

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

zongertinib

pembrolizumab

cisplatin

carboplatin

pemetrexed

BupropionBupropion to Reduce Cancer Related Fatigue in Cancer Survivors

Recruiting

PHASE3

Sponsor:

University of Rochester NCORP Research Base

Location:

Fresno CA, Modesto CA, Stockton CA, Arroyo Grande CAshow 290 more

Code:

NCT03996265

Conditions

Be Diagnosed With Cancer and Have Completed Systemic Therapy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bupropion Hydrochloride Controlled-release

Placebo Administration

Quality-of-Life Assessment

Questionnaire Administration

Tendyne TranscatheterClinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation

Recruiting

Sponsor:

Abbott Medical Devices

Location:

Fresno CA, Stanford CA, Sacramento CA, San Francisco CAshow 64 more

Code:

NCT03433274

Conditions

Mitral Regurgitation

Mitral Insufficiency

Mitral Valve Insufficiency

Cardiovascular Diseases

Valve Disease, Heart

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tendyne Mitral Valve System

MitraClip System

SeralutinibEfficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)

Recruiting

PHASE3

Sponsor:

GB002, Inc.

Location:

Fresno CA, Stanford CA, Sacramento CA, Santa Barbara CAshow 51 more

Code:

NCT05934526

Conditions

Pulmonary Arterial Hypertension

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Placebo

Seralutinib

Generic Dry Powder Inhaler

LevocarnitineStudying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma

Recruiting

PHASE3

Sponsor:

Children's Oncology Group

Location:

Madera CA, Arroyo Grande CA, Palo Alto CA, Oakland CAshow 138 more

Code:

NCT05602194

Conditions

B Acute Lymphoblastic Leukemia

B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1

B Acute Lymphoblastic Leukemia, BCR-ABL1-Like

Lymphoblastic Lymphoma

Mixed Phenotype Acute Leukemia

Eligibility Criteria

Sex: All

Age: 15 - 40

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Calaspargase Pegol

Levocarnitine

Pegaspargase

Quality-of-Life Assessment

CrizotinibCrizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)

Recruiting

PHASE3

Sponsor:

ECOG-ACRIN Cancer Research Group

Location:

Fresno CA, Clovis CA, Modesto CA, Bakersfield CAshow 977 more

Code:

NCT02201992

Conditions

ALK Gene Rearrangement

ALK Gene Translocation

ALK Positive

Stage IB Non-Small Cell Lung Carcinoma AJCC v7

Stage II Non-Small Cell Lung Cancer AJCC v7

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Clinical Observation

Crizotinib

Laboratory Biomarker Analysis